NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-047-2014-0-FR-09 Multi-Epitope TARP Peptide Vaccine And Uses Thereof FR EP 14831120.2 Issued
NCI E-047-2014-0-CH-11 Multi-Epitope TARP Peptide Vaccine And Uses Thereof CH EP 14831120.2 Issued
NCI E-047-2014-0-GB-10 Multi-Epitope TARP Peptide Vaccine And Uses Thereof GB EP 14831120.2 Issued
NCI E-081-2015-1-AU-02 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES AU National Stage 2013271428 Abandoned
NCI E-047-2014-0-PCT-02 Multi-Epitope TARP Peptide Vaccine And Uses Thereof PCT PCT PCT/US2014/070144 Expired
NCI E-077-2017-0-US-03 CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE US National Stage 14/407,419 10286064 Issued PDF
NIA E-051-2008-0-JP-10 Compositions and Methods for Delivering Inhibitory Oligonucleotides JP DIV 2014-250963 Abandoned
NCI E-248-2016-0-US-01 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer US 62/089,631 Abandoned
NCATS E-203-2012-0-US-07 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 US National Stage 14/406,401 9730941 Issued PDF
NCI E-081-2015-1-JP-05 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES JP National Stage 2015-516235 Issued
NICHD E-032-2008-0-US-05 Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax. US DIV 14/563,920 Abandoned
NCI E-021-2015-0-US-01 Anti-CD70 Chimeric Antigen Receptors US 62/088,882 Abandoned
NCATS E-203-2012-0-JP-06 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 JP National Stage 2015-516246 Issued
NCI E-269-2011-0-JP-05 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) JP National Stage 2015-516223 Issued
NCI E-081-2015-1-US-06 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES US National Stage 14/406,161 9676858 Issued PDF
NIDCR E-036-2010-1-US-04 Compositions and Methods for Screening For Lyme Disease US DIV 14/562,068 9310367 Issued PDF
NIAID E-242-2014-0-PCT-02 A Monoclonal Antibody Against The N-terminal Portion Of The Circumsporozoite Protein Of Plasmodium Falciparum PCT PCT PCT/US14/068731 Expired
NIDCR E-485-2013-0-PCT-02 Methods of Treating or Preventing Pruritis by Blocking Natriuretic Polypeptide B PCT PCT PCT/US2014/068541 Expired
NCI E-269-2011-0-US-06 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) US National Stage 14/405,696 Abandoned
NIAID E-045-2015-0-US-01 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US 62/087,087 Abandoned
NCI E-186-2007-2-US-07 Papillomavirus Pseudoviruses For Detection And Therapy Of Tumors US CON 14/558,301 10188751 Issued PDF
NCI E-087-2005-0-US-08 Custom Vectors For Treating And Preventing Pancreatic Cancer US CON 14/556,897 Abandoned
NCI E-136-2012-0-JP-04 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof JP National Stage 2015-515243 Issued
NCI E-184-2009-0-JP-13 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS JP DIV 2014-240182 Abandoned
NCI E-230-2011-1-NL-18 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use NL EP 13720737.9 Issued
NCI E-230-2011-1-LI-17 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use LI EP 13720737.9 Issued
NCI E-230-2011-1-BE-08 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use BE EP 13720737.9 Issued
NCI E-230-2011-1-CH-09 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use CH EP 13720737.9 Issued
NCI E-230-2011-1-GB-14 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use GB EP 13720737.9 Issued
NCI E-230-2011-1-DK-11 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use DK EP 13720737.9 Issued
NCI E-230-2011-1-IE-15 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use IE EP 13720737.9 Issued
NCI E-230-2011-1-IT-16 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use IT EP 13720737.9 Issued
NCI E-230-2011-1-FR-13 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use FR EP 13720737.9 Issued
NCI E-230-2011-1-DE-10 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use DE EP 13720737.9 Issued
NCI E-230-2011-1-PT-19 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use PT EP 13720737.9 Issued
NCI E-230-2011-1-ES-12 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use ES EP 13720737.9 Issued
NCI E-200-1998-0-CA-38 Bisufran Derivatives Useful in Preventing the Emergence of Multidrug Resistnat HIV Strains and Treatment of HIV CA DIV 2872424 Expired
NIDCR E-105-2003-0-US-04 Avian Adenoassociated Virus and Uses Thereof US DIV 14/554,728 9238800 Expired PDF
NIDDK E-011-2014-0-TW-03 Heterocyclic Compounds and Methods of Use Thereof TW ORD 103141004 Abandoned
NCI E-040-2012-0-CN-07 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen CN National Stage 201380027676.3 Abandoned
NCI E-028-2015-0-US-01 Anti-Mutated KRAS T Cell Receptors US 62/084,654 Abandoned
NCATS E-214-2014-0-US-01 Small Molecule Aldehyde Dehydrogenase Inhibitors and Methods of Use Thereof US 62/084,830 Abandoned
NIAID E-170-2013-1-CA-03 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION CA National Stage 2930587 Issued
NICHD E-552-2013-0-BR-04 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE BR National Stage BR112016011997-5 Issued
NICHD E-552-2013-0-CA-05 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CA National Stage 2930872 Issued
NICHD E-552-2013-0-MX-11 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE MX National Stage MX/a/2016/006774 Issued
NICHD E-552-2013-0-AU-03 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE AU National Stage 2014354839 Issued
NICHD E-552-2013-0-CN-06 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CN National Stage 201480074046.6 Issued
NICHD E-552-2013-0-IL-09 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE IL National Stage 245659 Issued
NICHD E-552-2013-0-JP-10 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE JP National Stage 2016-554828 Issued